Healing Thresholds - Connecting Community and Science to Heal Autism

olanzapine

Olanzapine in the Treatment of Behavioral Problems Associated with Autism: An Open-Label Trial in Kuwait Fido, A.; AlSaad, S. , Medical Principles and Practices, Volume 17, Issue 5, p.415-418, (2008) Layperson Summary

Atypical Antipsychotics in Children and Adolescents with Autistic and Other Pervasive Developmental Disorders McDougle, C.; Stigler, K.; Erickson, C.; Posey, D. , J Clin Psychiatry, Volume 69, Issue Suppl 4, p.15-20, (2008) Layperson Summary

Cessation of Risperidone-Induced Incontinency by Valproate in a Child with Pervasive Developmental Disorder Ghanizadeh, A.; Kianpoor, M. , Primary Psychiatry, Volume 15, Issue 4, p.32-34, (2007) Layperson Summary

Risperidone-Induced Double Incontinence Herguner, S.; Mukaddes, N. , Progress in Neuro-Psychomarmacology & Biological Psychiatry, Volume 32, Issue 4, p.1085-1086, (2008) Layperson Summary

Atypical Antipsychotics in Children with Pervasive Developmental Disorders Chavez, B.; Chavez-Brown, M.; Sopko, M.; Rey, J. , Pediatric Drugs, Volume 9, Issue 4, p.249-266, (2007) Layperson Summary

Use of Atypical Antipsychotics in the Treatment of Autistic Disorder Stachnik, J.; Nunn-Thompson, C. , The Annals of Pharmacology, Volume 41, Issue 4, p.626-634, (2007) Layperson Summary

A Double-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder Hollander, E.; Wasserman, S.; Swanson, E.; Chaplin, W.; Schapiro, M.; Zagursky, K.; Novotny, S. , Journal of Child and Adolescent Pharmacology, Volume 16, Issue 5, p.541-548, (2006) Layperson Summary

Effects of Development on Olanzapine-Associated Adverse Events Woods, S.; Martin, A.; Spector, S.; McGlashan, T. , J. Am. Acad. Child Adolesc. Psychiatry, Volume 41, Issue 12, p.1439-1446, (2002) Layperson Summary